About
Performance
Portfolio
Reporting
Contact

Contact WertArt

Name(required)

Email(required)

Website

Comment(required)

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 475 other subscribers

Email Address

Recent Comments

WertArt on Gilead Sciences (NASDAQ:GILD)
Cornelius on Gilead Sciences (NASDAQ:GILD)
WertArt on Gilead Sciences (NASDAQ:GILD)
Cornelius on Gilead Sciences (NASDAQ:GILD)
defensiven on Gilead Sciences (NASDAQ:GILD)

Recent Posts

Gilead Sciences (NASDAQ:GILD)
Q1 2017 Performance Review
Addition to Italian Real Estate Funds
Sell Passat SA
Sell Lectra

Recommended Links

Assetguard
Bronte Capital
Damodaran
Essays from the Capital Cycle investors
Farnam Street
Keep on track
Swiss financial markets commentary
valueandopportunity
Views from Down Under

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 475 other subscribers

Email Address

CyberChimps WordPress Themes

© WertArt Capital

WordPress Backup